1
|
Lumley SF, Richens N, Lees E, Cregan J, Kalimeris E, Oakley S, Morgan M, Segal S, Dawson M, Walker AS, Eyre DW, Crook DW, Beer S, Novak A, Stoesser NE, Matthews PC. Changes in paediatric respiratory infections at a UK teaching hospital 2016-2021; impact of the SARS-CoV-2 pandemic. J Infect 2021; 84:40-47. [PMID: 34757137 PMCID: PMC8591975 DOI: 10.1016/j.jinf.2021.10.022] [Citation(s) in RCA: 36] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2021] [Revised: 10/25/2021] [Accepted: 10/26/2021] [Indexed: 01/21/2023]
Abstract
Objective To describe the impact of the SARS-CoV-2 pandemic on the incidence of paediatric viral respiratory tract infection in Oxfordshire, UK. Methods Data on paediatric Emergency Department (ED) attendances (0-15 years inclusive), respiratory virus testing, vital signs and mortality at Oxford University Hospitals were summarised using descriptive statistics. Results Between 1-March-2016 and 30-July-2021, 155,056 ED attendances occurred and 7,195 respiratory virus PCRs were performed. Detection of all pathogens was suppressed during the first national lockdown. Rhinovirus and adenovirus rates increased when schools reopened September-December 2020, then fell, before rising in March-May 2021. The usual winter RSV peak did not occur in 2020/21, with an inter-seasonal rise (32/1,000 attendances in 0-3 yr olds) in July 2021. Influenza remained suppressed throughout. A higher paediatric early warning score (PEWS) was seen for attendees with adenovirus during the pandemic compared to pre-pandemic (p = 0.04, Mann-Witney U test), no other differences in PEWS were seen. Conclusions SARS-CoV-2 caused major changes in the incidence of paediatric respiratory viral infection in Oxfordshire, with implications for clinical service demand, testing strategies, timing of palivizumab RSV prophylaxis, and highlighting the need to understand which public health interventions are most effective for preventing respiratory virus infections.
Collapse
Affiliation(s)
- Sheila F Lumley
- NHS Foundation Trust, Oxford University Hospitals, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Medawar Building, South Parks Road, Oxford OX1 3SY, UK.
| | | | - Emily Lees
- Department of Paediatrics, University of Oxford, Oxford UK
| | - Jack Cregan
- Nuffield Department of Medicine, University of Oxford, Medawar Building, South Parks Road, Oxford OX1 3SY, UK
| | | | - Sarah Oakley
- NHS Foundation Trust, Oxford University Hospitals, Oxford, UK
| | - Marcus Morgan
- NHS Foundation Trust, Oxford University Hospitals, Oxford, UK
| | - Shelley Segal
- NHS Foundation Trust, Oxford University Hospitals, Oxford, UK
| | - Moya Dawson
- NHS Foundation Trust, Oxford University Hospitals, Oxford, UK
| | - A Sarah Walker
- Nuffield Department of Medicine, University of Oxford, Medawar Building, South Parks Road, Oxford OX1 3SY, UK; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK
| | - David W Eyre
- NHS Foundation Trust, Oxford University Hospitals, Oxford, UK; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK; Nuffield Department of Population Health, University of Oxford, Oxford, UK; Big Data Institute, University of Oxford, Oxford, UK
| | - Derrick W Crook
- NHS Foundation Trust, Oxford University Hospitals, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Medawar Building, South Parks Road, Oxford OX1 3SY, UK; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK
| | - Sally Beer
- NHS Foundation Trust, Oxford University Hospitals, Oxford, UK
| | - Alex Novak
- NHS Foundation Trust, Oxford University Hospitals, Oxford, UK
| | - Nicole E Stoesser
- NHS Foundation Trust, Oxford University Hospitals, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Medawar Building, South Parks Road, Oxford OX1 3SY, UK; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK
| | - Philippa C Matthews
- NHS Foundation Trust, Oxford University Hospitals, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Medawar Building, South Parks Road, Oxford OX1 3SY, UK; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK.
| |
Collapse
|
5
|
Corbet A, Cregan J, Frink J, Rudolph AJ. Distention-produced phospholipid secretion in postmortem in situ lungs of newborn rabbits. Inhibition by specific beta-adrenergic blockade. Am Rev Respir Dis 1983; 128:695-701. [PMID: 6688707 DOI: 10.1164/arrd.1983.128.4.695] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
The secretion of total phospholipid in postmortem in situ lungs of newborn rabbits was examined using the technique of lung lavage after an initial lavage procedure, and then after a period of static air inflation at 30 cm H2O pressure for 45 min. There was a significant reduction in the phospholipid yield with 10(-3) molar DL-propranolol used as the initial lavage fluid, both immediately after the initial lavage procedure (experimental group, 0.29 +/- SE 0.04 mg/g dry lung weight; control group, 0.57 +/- SE 0.09; p less than 0.01) and after static inflation with air (experimental group, 1.14 +/- SE 0.15; control group, 2.22 +/- SE 0.24; p less than 0.001). Preinjection of the breathing newborn rabbit with DL-propranolol was not necessary for this inhibitory effect. There was no significant reduction when 10(-3) molar atropine, lidocaine, D-propranolol, or 10(-5) scopolamine were substituted as the initial lavage fluid, nor was there any reduction when the concentration of DL-propranolol was decreased to 10(-4) or 10(-5) molar. Because D-propranolol has all the properties of DL-propranolol, except 100-fold less beta-adrenergic antagonist activity, the inhibition by propranolol was due to specific beta-adrenergic blockade. In the absence of an intact circulation or a functional central nervous system, it is concluded that surfactant phospholipid secretion is partly controlled by an intrapulmonary neurogenic reflex.
Collapse
|